KOD•benzinga•
Kodiak Sciences Completes Enrollment In Second Registrational Trial Of Tarcocimab In Patients With Diabetic Retinopathy; Topline Clinical Data Of The Confirmatory Registrational Study GLOW2 Expected In Q1 2026
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on March 10, 2025 by benzinga